Biostar Pharmaceuticals, Inc. Increase (Decrease) in Derivative Liabilities
Biostar Pharmaceuticals, Inc. reported Increase (Decrease) in Derivative Liabilities of -$289.33 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2017-11-20
- Biostar Pharmaceuticals, Inc. increase (decrease) in derivative liabilities for the quarter ending 2017-09-30 was -$12.93K.
- Biostar Pharmaceuticals, Inc. increase (decrease) in derivative liabilities for the quarter ending 2017-06-30 was -$259.44K.
- Biostar Pharmaceuticals, Inc. increase (decrease) in derivative liabilities for the quarter ending 2017-03-31 was -$16.97K.
- Biostar Pharmaceuticals, Inc. increase (decrease) in derivative liabilities for the quarter ending 2016-12-31 was -$180.61K.
- Biostar Pharmaceuticals, Inc. increase (decrease) in derivative liabilities for fiscal 2016 was -$227.11K.
- Biostar Pharmaceuticals, Inc. increase (decrease) in derivative liabilities for fiscal 2015 was -$324.09K.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$12.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | -$272.37K derived: sum of 2 quarters · filed 2017-11-20 | -$289.33K 10-Q · filed 2017-11-20 | -$469.94K derived: sum of 4 quarters · filed 2017-11-20 |
| 2017-06-30 | -$259.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-15 | -$276.41K 10-Q · filed 2017-11-15 | -$457.01K derived: sum of 3 quarters · filed 2017-11-15 | -$459.16K derived: sum of 4 quarters · filed 2017-11-15 |
| 2017-03-31 | -$16.97K 10-Q · filed 2017-05-19 | -$197.57K derived: sum of 2 quarters · filed 2017-05-19 | -$199.72K derived: sum of 3 quarters · filed 2017-05-19 | -$215.88K derived: sum of 4 quarters · filed 2017-05-19 |
| 2016-12-31 | -$180.61K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13 | -$182.76K derived: sum of 2 quarters · filed 2017-04-13 | -$198.91K derived: sum of 3 quarters · filed 2017-04-13 | -$227.11K 10-K · filed 2017-04-13 |
| 2016-09-30 | -$2.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-21 | -$18.31K derived: sum of 2 quarters · filed 2016-11-21 | -$46.50K 10-Q · filed 2016-11-21 | -$145.93K derived: sum of 4 quarters · filed 2016-11-21 |
| 2016-06-30 | -$16.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-22 | -$44.35K 10-Q · filed 2016-08-22 | -$143.78K derived: sum of 3 quarters · filed 2016-08-22 | -$287.99K derived: sum of 4 quarters · filed 2016-08-22 |
| 2016-03-31 | -$28.19K 10-Q · filed 2016-05-23 | -$127.62K derived: sum of 2 quarters · filed 2016-05-23 | -$271.83K derived: sum of 3 quarters · filed 2016-05-23 | -$362.15K derived: sum of 4 quarters · filed 2016-05-23 |
| 2015-12-31 | -$99.43K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | -$243.64K derived: sum of 2 quarters · filed 2016-04-14 | -$333.96K derived: sum of 3 quarters · filed 2016-04-14 | -$324.09K 10-K · filed 2016-04-14 |
| 2015-09-30 | -$144.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-23 | -$234.53K derived: sum of 2 quarters · filed 2015-11-23 | -$224.66K 10-Q · filed 2015-11-23 | |
| 2015-06-30 | -$90.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | -$80.45K 10-Q · filed 2015-08-19 | ||
| 2015-03-31 | $9.87K 10-Q · filed 2015-05-15 |